Discovery of indazoles as inhibitors of Tpl2 kinase
Authors:
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (16) , 4758-4761
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritisBioorganic & Medicinal Chemistry Letters, 2006
- Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure–activity relationshipsBioorganic & Medicinal Chemistry Letters, 2005
- MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α ProteinCurrent Medicinal Chemistry, 2005
- Phosphorylation of Threonine 290 in the Activation Loop of Tpl2/Cot Is Necessary but Not Sufficient for Kinase ActivityJournal of Biological Chemistry, 2004
- Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3 S)thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-α-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid ArthritisThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Inhibition of p38 MAP kinase by utilizing a novel allosteric binding siteNature Structural & Molecular Biology, 2002
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Cytokine Pathways and Joint Inflammation in Rheumatoid ArthritisNew England Journal of Medicine, 2001
- The Role of TNFα and IL-1 in Rheumatoid Arthritis2000
- The Proto-Oncogene Cot Kinase Participates in CD3/CD28 Induction of NF-κB Acting through the NF-κB-Inducing Kinase and IκB KinasesImmunity, 1999